Abeona Therapeutics Inc

Abeona Therapeutics Inc

ABEO

Get informed when a big investor buys or sells

+ Follow
Market Cap$329.43M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Abeona Therapeutics IncAbeona Therapeutics Inc4.9-46%-0.2
$17.00

Target Price by Analysts

199.8% upsideAbeona Therapeutics Target Price DetailsTarget Price
$0.26

Current Fair Value

95.4% downside

Overvalued by 95.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$329.43 Million
Enterprise Value$291.66 Million
Dividend Yield$- (-)
Earnings per Share$1.34
Beta1.34
Outstanding Shares56,620,920

Return

Return on Equity45.63%ROE
Return on Assets33.32%
Return on Invested Capital-60.59%

Valuation & Multiples

P/E Ratio4.95P/E Ratio
PEG11.8PEG
Price to Sales-Price to Sales
Price to Book Ratio2.84Price to Book Ratio
Enterprise Value to Revenue20.06
Enterprise Value to EBIT-2.87
Enterprise Value to Net Income4
Total Debt to Enterprise0.08
Debt to Equity0.16Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 21, 2026
EPS Estimate
$-0.34
Average shareholder expectation
Revenue Estimate
$4.57 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 13, 2026
EPS Estimate
$-0.23
Average shareholder expectation
Revenue Estimate
$12.24 M
Average shareholder expectation

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

ESG Score

No data

About Abeona Therapeutics Inc

CEO: Joao Siffert